| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |